Publications by authors named "J Castela"

Claim this Profile
L
Longitudinal profiles of fecal calprotectin and C-reactive protein in relation to outcomes in Crohn's disease patients on infliximab.
Fernando Magro, Beatriz Domingues, Maria Manuela Estevinho, Marta Patita, Bruno Arroja, Joana Castela

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes.
D Magalhaes, M Santiago, M Patita, B Arroja, P Lago, J Castela

United European Gastroenterol J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients.
Fernando Magro, Samuel Fernandes, Marta Patita, Bruno Arroja, Paula Lago, Joana Castela

J Crohns Colitis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab.
Paula Sousa, Marta Patita, Bruno Arroja, Paula Lago, Isadora Rosa, Joana Castela

Dig Liver Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study.
Fernando Magro, Maria Manuela Estevinho, Gaia Catalano, Marta Patita, Bruno Arroja, Joana Castela

United European Gastroenterol J· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis